IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Xu, Lingxiao ^a   Feng, Xiaoke ^a   Tan, Wenfeng ^a   Gu, Weijuan ^a   Guo, Dunming ^a   Zhang, Miaojia ^a   Wang, Fang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 28A; INTERLEUKIN 29; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PEPTIDOGLYCAN; POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; CYTOKINE RECEPTOR; IL29 PROTEIN, HUMAN; INTERLEUKIN 28ALPHA RECEPTOR; INTERLEUKIN DERIVATIVE; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID;

ADAPTIVE IMMUNITY; ARTICLE; CELL VIABILITY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; UPREGULATION; CELL LINE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; PATHOLOGY; SYNOVIUM;

ARTHRITIS, RHEUMATOID; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN; POLY I-C; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-10; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 84886424618     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4357     Document Type: Article

References (30)

1. Witte K, Witte E, Sabat R, Wolk K. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev 2010, 21:237-251. 10.1016/j.cytogfr.2010.04.002, 20655797.
2. Kotenko SV. IFN-λs. Curr Opin Immunol 2011, 23:583-590. 10.1016/j.coi.2011.07.007, 3196341, 21840693.
3. Donnelly RP, Kotenko SV. Interferon-λ: a new addition to an old family. J Interferon Cytokine Res 2010, 30:555-564. 10.1089/jir.2010.0078, 2925029, 20712453.
4. Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RT. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. J Hepatol 2011, 55:289-298. 10.1016/j.jhep.2010.11.019, 3068235, 21147189.
5. Liu MQ, Zhou DJ, Wang X, Zhou W, Ye L, Li JL, Wang YZ, Ho WZ. IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway. PLoS One 2012, 7:e35902. 10.1371/journal.pone.0035902, 3338759, 22558263.
6. Jordan WJ, Eskdale J, Srinivas S, Pekarek V, Kelner D, Rodia M, Gallagher G. Human interferon λ-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007, 8:254-261. 10.1038/sj.gene.6364382, 17361203.
7. Srinivas S, Dai J, Eskdale J, Gallagher GE, Megjugorac NJ, Gallagher G. Interferon-λ1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology 2008, 125:492-502. 10.1111/j.1365-2567.2008.02862.x, 2612545, 18547367.
8. Jordan WJ, Eskdale J, Boniotto M, Rodia M, Kellner D, Gallagher G. Modulation of the human cytokine response by interferon λ-1 (IFN-λ1/IL-29). Genes Immun 2007, 8:13-20. 10.1038/sj.gene.6364348, 17082759.
9. He S, Li T, Chen H, Ma W, Yao Q, Yang H, Wang H, Wang F, Zhao C, Yang P. CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation. Allergy 2011, 66:238-246. 10.1111/j.1398-9995.2010.02455.x, 20726961.
10. He S, Zhang H, Chen H, Yang H, Huang T, Chen Y, Lin J, Wang F, Chen X, Li TL, Yang P. Expression and release of IL-29 by mast cells and modulation of mast cell behavior by IL-29. Allergy 2010, 65:1234-1241. 10.1111/j.1398-9995.2010.02349.x, 20337614.
11. Wu Q, Yang Q, Lourenco E, Sun H, Zhang Y. Interferon-λ1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity. Arthritis Res Ther 2011, 13:R88. 10.1186/ar3363, 3218903, 21679442.
12. Lin SC, Kuo CC, Tsao JT, Lin LJ. Profiling the expression of interleukin (IL)-28 and IL-28 receptor α in systemic lupus erythematosus patients. Eur J Clin Invest 2012, 42:61-69. 10.1111/j.1365-2362.2011.02557.x, 21707611.
13. Wang F, Xu L, Feng X, Guo D, Tan W, Zhang M. Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis. Arthritis Res Ther 2012, 14:R228. 10.1186/ar4067, 3580539, 23078630.
14. Einsele H, Steidle M, Müller C, Fritz P, Zacher J, Schmidt H, Saal J. Demonstration of cytomegalovirus (CMV) DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis. J Rheumatol 1992, 19:677-681.
15. Müller C, Einsele H. Influence of human cytomegalovirus on immune reconstitution after bone marrow transplantation. Ann Hematol 1992, 64:140-142. 10.1007/BF01697401, 1571409.
16. Saal JG, Krimmel M, Steidle M, Gerneth F, Wagner S, Fritz P, Koch S, Zacher J, Sell S, Einsele H. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum 1999, 42:1485-1496. 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7, 10403278.
17. Sacre SM, Andreakos E, Kiriakidis S, Amjadi P, Lundberg A, Giddins G, Feldmann M, Brennan F, Foxwell BM. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 2007, 170:518-525. 10.2353/ajpath.2007.060657, 1851858, 17255320.
18. Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY, Lee SY, Park MK, Min JK, Park SH. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunology Lett 2007, 108:121-128.
19. Jung YO, Cho ML, Kang CM, Jhun JY, Park JS, Oh HJ, Min JK, Park SH, Kim HY. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunology Lett 2007, 109:21-27.
20. Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, Wagner U, Hantzschel H, Michel BA, Gay RE, Gay S. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004, 172:1256-1265.
21. Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 2008, 223:252-270. 10.1111/j.1600-065X.2008.00648.x, 18613841.
22. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum 2005, 52:2656-2665. 10.1002/art.21273, 16142732.
23. Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 2003, 48:642-650. 10.1002/art.10848, 12632416.
24. Roelofs M, Wenink M, Brentano F, Abdollahi-Roodsaz S, Oppers-Walgreen B, Barrera P, van Riel P, Kyburz D, van den Berg W, Radstake T. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis 2009, 68:1486-1493. 10.1136/ard.2007.086421, 18765427.
25. Liu BS, Janssen HL, Boonstra A. IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression. Blood 2011, 117:2385-2395. 10.1182/blood-2010-07-298976, 21190998.
26. Miyazawa K, Mori A, Okudaira H. Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J Biochem 1998, 124:1153-1162. 10.1093/oxfordjournals.jbchem.a022233, 9832620.
27. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, Yao L, Liu H, Barahmand-pour F, Sivakumar P, Chan C, Birks C, Foster D, Clegg CH, Wietzke-Braun P, Mihm S, Klucher KM. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 2006, 44:896-906. 10.1002/hep.21312, 17006906.
28. Mennechet FJ, Uze G. Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 2006, 107:4417-4423. 10.1182/blood-2005-10-4129, 16478884.
29. Makela SM, Osterlund P, Julkunen I. TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells. Mol Immunol 2011, 48:505-515. 10.1016/j.molimm.2010.10.005, 21040977.
30. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J Immunol 2008, 180:2474-2485.